Navigation Links
Revised GAAP earnings guidance for AbbVie Inc for the Financial Year ending December 31, 2014 and Third Quarter ending September 30, 2014; Confirms Adjusted Earnings Guidance
Date:9/3/2014

cipates will be applicable for the full year ending December 31, 2014.

AbbVie has prepared the AbbVie Profit Forecasts based on unaudited interim financial results for the six months ended June 30, 2014 and a forecast to December 31, 2014 and September 30, 2014.

3.            Assumptions

AbbVie has prepared the AbbVie Profit Forecasts on the basis of the following assumptions:

Factors outside the influence or control of AbbVie and its Directors

  • There will be no material change to the existing prevailing global macroeconomic and political conditions during the year ended December 31, 2014.
  • The Euro, British pound and Japanese yen and other exchange rates, and inflation and tax rates in AbbVie's principal markets will remain materially unchanged from the prevailing rates.
  • There will be no material change in legislation or regulatory requirements impacting on AbbVie's operations or its accounting policies.
  • There will be no material change in AbbVie's labor costs, including medical and pension and other post-retirement benefits driven by external parties or regulations.
  • There will be no material adverse events that will have a significant impact on AbbVie's financial performance.

Factors within the influence or control of AbbVie and its Directors

  • The AbbVie Profit Forecast excludes any material acquisitions or disposals yet to be announced in the year ended December 31, 2014.
  • The AbbVie Profit Forecast excludes any exceptional transaction, financing or transition costs associated with the proposed transaction with Shire plc.
  • Current separation plans and costs as part of the Transition Service Agreement with Abbott will conclude materially as AbbVie would reasonably expect based on AbbVie's past e
    '/>"/>

SOURCE AbbVie
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. International Probiotics Association Excited To Learn The FDA Has Decided To Issue A New, Revised NDI Draft Guidance
2. Luminex Corporation Fourth Quarter and Full Year 2011 Earnings Release Scheduled for February 6, 2012
3. Preliminary Figures for 2011: Sartorius Grows at Double-Digit Rates and Boosts Operating Earnings by More Than 30%
4. Bacterin International Holdings, Inc. Schedules Fourth Quarter 2011 Financial Earnings Conference Call
5. WuXi PharmaTech Schedules Second-Quarter 2012 Earnings Release
6. Life Technologies Sets 2nd Quarter 2012 Earnings Release Date for Tuesday, July 31, 2012
7. Haemonetics Reports First Quarter Fiscal 2013 Results, Completes Acquisition of Palls Transfusion Medicine Business, Affirms Fiscal 2013 Earnings Guidance, Provides Preliminary Outlook for Fiscal 2014 and Announces Share Repurchase
8. Perrigo Reports Record Fourth Quarter and Fiscal Year Revenue, Earnings and Cash Flow From Operations
9. Cambrex Reschedules Third Quarter 2012 Financial Results and Earnings Call Date to November 5, 2012
10. Sigma-Aldrich Announces Q4 2012 Earnings Conference Call
11. Zynga, Inc. Fourth-Quarter Earnings and Sales Topped Wall Street Estimates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... September 18, 2014 ... http://www.researchandmarkets.com/research/czvg3s/biocompatible ) has announced the addition ... Global Strategic Business Report" report ... ,This report analyzes the worldwide markets ... by the following Product Segments: Polymeric ...
(Date:9/18/2014)... , Sept. 18, 2014 Research and ... "Global and Chinese Stem Cell Industry Report, 2014-2017" ... are undifferentiated biological cells that can differentiate into specialized ... stem cells. Stem cell therapy can be applied to ... system disease), nervous system diseases, damage or lesion of ...
(Date:9/18/2014)... Sept. 18, 2014 Research and Markets ... Companion Diagnostics (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry) Market ... their offering. The global companion diagnostics ... 22.7% from 2014 to 2019. Factors such as rising ... of companion diagnostics by the pharmaceutical industry, support from ...
(Date:9/18/2014)...  MEI Pharma, Inc. (Nasdaq: MEIP ), an ... for cancer, announced today that Daniel P. Gold , ... NewsMakers in the Biotech Industry conference on Friday, ... Millennium Broadway Hotel & Conference Center in New ... be accessed at www.meipharma.com . A replay will be ...
Breaking Biology Technology:Biocompatible Materials - Global Strategic Business Report 2014 2Biocompatible Materials - Global Strategic Business Report 2014 3Global and Chinese Stem Cell Industry Report, 2014-2017 2Global and Chinese Stem Cell Industry Report, 2014-2017 3Global Companion Diagnostics (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry) Market - Trends & Forecasts to 2019 2Global Companion Diagnostics (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry) Market - Trends & Forecasts to 2019 3MEI Pharma To Present At BioCentury's NewsMakers Conference 2MEI Pharma To Present At BioCentury's NewsMakers Conference 3
... half of Americans living with colorectal cancer will ... course of their disease. Radiofrequency ablation, a minimally ... tumor causing cancer cell death with minimal associated ... prolongation of their life by nearly three years, ...
... a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results for the year ended 2009 will be released on Tuesday, March 23, 2010 ... , ... ... ...
... , March 16, 2010 Elbit Imaging,(NASDAQ: EMITF ) ("Elbit Imaging" "Company") announced today that its,wholly-owned subsidiary, Elbit Medical Ltd., ... the Tel Aviv,Stock Exchange. , ... , ... ...
Cached Biology Technology:Living longer: Colon cancer patients gain time with radiofrequency ablation treatment 2Living longer: Colon cancer patients gain time with radiofrequency ablation treatment 3PharmAthene to Host Year-End 2009 Earnings Conference Call and Webcast on Tuesday, March 23, 2010 2PharmAthene to Host Year-End 2009 Earnings Conference Call and Webcast on Tuesday, March 23, 2010 3Elbit Imaging Announces Filing of Draft Prospectus for its Subsidiary Elbit Medical Ltd. for Float on Tel Aviv Stock Exchange 2Elbit Imaging Announces Filing of Draft Prospectus for its Subsidiary Elbit Medical Ltd. for Float on Tel Aviv Stock Exchange 3Elbit Imaging Announces Filing of Draft Prospectus for its Subsidiary Elbit Medical Ltd. for Float on Tel Aviv Stock Exchange 4Elbit Imaging Announces Filing of Draft Prospectus for its Subsidiary Elbit Medical Ltd. for Float on Tel Aviv Stock Exchange 5Elbit Imaging Announces Filing of Draft Prospectus for its Subsidiary Elbit Medical Ltd. for Float on Tel Aviv Stock Exchange 6
(Date:9/18/2014)... ever starts a "frequent flyers" program, fruit flies surely ... laboratory has hosted increasing numbers of fruit fly research ... station in April, and another is scheduled launch to ... to launch in December. , Fruit flies are biomedical ... in space. Model organisms can reveal the basis for ...
(Date:9/18/2014)... have built the first smartphone app that automatically ... trends. In other words, your smartphone knows your ... -- and how that affects you. , The ... and loneliness to their academic performance, also may ... example, to monitor mental health, trigger intervention and ...
(Date:9/18/2014)... tropical rabbitfish which have devastated algal forests in the ... entire Mediterranean basin if their distribution continues to expand ... study, by an international team of researchers led by ... Tomas of the Mediterranean Institute for Advanced Studies in ... ., Members of the team surveyed more than 1000 ...
Breaking Biology News(10 mins):Buzzing with activity: Fruit flies orbit Earth for science 2Buzzing with activity: Fruit flies orbit Earth for science 3Buzzing with activity: Fruit flies orbit Earth for science 4New Dartmouth smartphone app reveals users' mental health, performance, behavior 2New Dartmouth smartphone app reveals users' mental health, performance, behavior 3New Dartmouth smartphone app reveals users' mental health, performance, behavior 4Tropical fish a threat to Mediterranean Sea ecosystems 2
... metal scaffolds inserted into blood vessels, to better deliver ... the risk of inflammation that often negates initial benefits. ... an extremely thin layer to bare metal surfaces, may ... make use of metallic implants. , Cardiologists frequently treat ...
... history's worst infectious diseases, but there are many more diseases ... society needs to confront to unlock the future promise of ... focus of a new report by the American Academy of ... been profound. Many diseases that formerly raged unchecked are ...
... flow of carbon through soil is ten times greater than the ... but until now how this happens was at best poorly understood. ... carbon. Now researchers at the University of Warwick have been able ... class of insects to expose the key underground carbon traffic system ...
Cached Biology News:Bare metal stents deliver gene therapy to heart vessels with less inflammation in animal studies 2Report focuses on challenges to unlocking future promise of vaccines 2Bugs expose underground carbon traffic system 10 times more important than fossil fuel burning 2
OmniSlide thermal Cycler for slide applications. 20 slide capacity. Humidity Chamber. Slide Rack can be transferred directly to Wash Module to avoid handling individual slides....
HyPro 100, includes 5 x HyPro20 and HyPro Cabinet. 100 slide capacity. Active vibration system, slide rack and humidity chamber. Ideal for microarray and in situ hybridization....
HyPro 20 system for slide hybridization. 20 slide capacity. Active vibration system, slide rack and humidity chamber. Ideal for microarray and in situ hybridization....
... are cytopathic effect inhibition assays, also known as ... tissue culture supernatents; serum from PK studies and ... is defined as the quantity of interferon required ... viral infection by 50%. All standards ...
Biology Products: